Table 1.
Complete blood count (CBC) in the preventive treatment arm
| MRL/MpJ | MRL/lpr-vehicle | MRL/lpr-tofacitinib | p value vehicle vs tofacitinib | |
|---|---|---|---|---|
| WBC (K/ul) | 3.00 ± 1.55 | 12.77 ± 3.64 | 10.35 ± 4.31 | p=0.1909 |
| RBC (M/ul) | 8.56 ± 0.55 | 7.92 ± 0.52 | 7.32 ± 0.72 | *, p=0.0431 |
| Hemoglobin (g/dL) | 13.76 ± 0.84 | 11.85 ± 0.7 | 10.78 ± 1.17 | *, p=0.0209 |
| Hematocrit (%) | 40.33 ± 2.60 | 34.7 ± 2.16 | 31.86 ± 2.63 | *, p=0.016 |
| MCV (fL) | 47.11 ± 0.74 | 43.85 ± 1.26 | 43.61 ± 0.98 | p=0.6414 |
| Platelets (K/ul) | 779.88 ± 159.74 | 647.73 ± 168.18 | 614.78 ± 255.07 | p=0.7326 |
| Polys (%) | 25.73 ± 4.84 | 12.22 ± 4.23 | 12.74 ± 8.58 | p=0.8604 |
| Lympho (%) | 47.64 ± 10.84 | 66.85 ± 10.06 | 64.20 ± 11.57 | p=0.5896 |
| Mono (%) | 14.36 ± 6.65 | 12.01 ± 7.07 | 17.11 ± 8.45 | p=0.1583 |
| Eosino (%) | 2.75 ± 1.52 | 2.78 ± 6.26 | 1.67 ± 1.41 | p=0.6084 |
| Baso (%) | 9.55 ± 3.10 | 6.15 ± 3.31 | 4.28 ± 4.57 | p=0.3031 |
| Poly (K/ul) | 0.75 ± 0.37 | 1.57 ± 0.77 | 1.29 ± 0.79 | p=0.4275 |
| Lympho (K/ul) | 0.75 ± 1.03 | 1.57 ± 3.22 | 1.29 ± 3.55 | p=0.2368 |
| Mono (K/ul) | 0.39 ± 0.21 | 1.40 ± 0.66 | 1.62 ± 0.74 | p=0.478 |
| Eosino (K/ul) | 0.08 ± 0.06 | 0.12 ± 0.12 | 0.16 ± 0.16 | p=0.4406 |
| Baso (K/ul) | 0.26 ± 0.11 | 0.71 ± 0.34 | 0.46 ± 0.48 | p=0.181 |
CBC count has been done by NIH Hematology Section